fg 5893 has been researched along with amperozide in 1 studies
| Studies (fg 5893) | Trials (fg 5893) | Recent Studies (post-2010) (fg 5893) | Studies (amperozide) | Trials (amperozide) | Recent Studies (post-2010) (amperozide) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 94 | 3 | 8 |
| Protein | Taxonomy | fg 5893 (IC50) | amperozide (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 0.8975 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hjorth, S; Pettersson, G | 1 |
1 other study(ies) available for fg 5893 and amperozide
| Article | Year |
|---|---|
5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Topics: Animals; Brain; Calcium; Citalopram; Hippocampus; Hydroxyindoleacetic Acid; Male; Neurons; Nicotinic Acids; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |